glp-1 for alcohol use disorder IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance disorders: An emerging pharmacotherapeutic target GLP-1s tied to lower alcohol

Vergote, I

In this study, the PA-induced reduction of GLP-1R level and PKA phosphorylation in HUVECs was reversed by either metformin or AMPK activator AICAR

However, patients diagnosed with Mast Cell Activation Syndrome (MCAS) or severe histamine intolerance must carefully navigate what functional medicine practitioners call the 'histamine paradox.' While NAC is a widely recognized mast cell stabilizer that effectively reduces ROS-triggered degranulation, it is also fundamentally a sulfur-containing amino acid derivative

Methionine and choline are established players in one-carbon metabolism

[1] Every day, your skin faces invisible threats: pollution, UV radiation, processed foods, emotional stress, and toxins

Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse